Connection

Claus Bachert to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Claus Bachert has written about Antibodies, Monoclonal, Humanized.
Claus Bachert
Connection Strength
0.484
Antibodies, Monoclonal, Humanized
  1. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.165
  2. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J Allergy Clin Immunol. 2017 Oct; 140(4):1024-1031.e14.
    View in: PubMed
    Score: 0.146
  3. COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab. J Allergy Clin Immunol. 2020 Jul; 146(1):218-220.e2.
    View in: PubMed
    Score: 0.045
  4. Conjunctivitis in dupilumab clinical trials. Br J Dermatol. 2019 09; 181(3):459-473.
    View in: PubMed
    Score: 0.041
  5. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps. J Allergy Clin Immunol Pract. 2017 Nov - Dec; 5(6):1512-1516.
    View in: PubMed
    Score: 0.036
  6. Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis. J Allergy Clin Immunol. 2015 Dec; 136(6):1431-1440.
    View in: PubMed
    Score: 0.033
  7. Rhinology Future Debates, an EUFOREA Report. Rhinology. 2017 Dec 01; 55(4):298-304.
    View in: PubMed
    Score: 0.009
  8. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology. 2017 Jun 01; 55(2):152-160.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.